Paper39593147
Exacerbated ischemic brain damage in type 2 diabetes via methylglyoxal-mediated miR-148a-3p decline.
Yang Z and 9 others. BMC Med, 2024. Cited by 13 papers, by iCite.
Cite this record
ConductScience Library. Exacerbated ischemic brain damage in type 2 diabetes via methylglyoxal-mediated miR-148a-3p decline. Papers, record 39593147. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39593147
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Exacerbated ischemic brain damage in type 2 diabetes via methylglyoxal-mediated miR-148a-3p decline.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| MicroRNAs | Major topic |
| Diabetes Mellitus, Type 2 | Major topic |
| Pyruvaldehyde | Major topic |
| Brain Ischemia | Major topic |
| Animals | |
| Mice | |
| Male | |
| Humans | |
| Disease Models, Animal | |
| Diabetes Mellitus, Experimental | |
| Mice, Inbred C57BL | |
| Blood-Brain Barrier |
Source PubMed
Grants5
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 82171344 | National Natural Science Foundation of China | PubMed | ||
| 81971079 | National Natural Science Foundation of China | PubMed | ||
| 2023A04J0439 | Science and Technology Projects in Guangzhou, China | PubMed | ||
| 2022A1515111052 | Basic and Applied Basic Research Foundation of Guangdong Province | PubMed | ||
| 2023B03J1351 | Science and Technology Projects in Guangzhou, China | PubMed |
Source PubMed
References48
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33323504 | The tight junction protein Claudin-5 limits endothelial cell motility. | J Cell Sci | 2021 | https://conductscience.org/library/papers/33323504 | PubMed |
| 2 | 2643202 | Reversible middle cerebral artery occlusion without craniectomy in rats. | Stroke | 1989 | https://conductscience.org/library/papers/2643202 | PubMed |
| 3 | 31790711 | The blood-brain barrier: Physiology and strategies for drug delivery. | Adv Drug Deliv Rev | 2020 | https://conductscience.org/library/papers/31790711 | PubMed |
| 4 | 34779951 | Linking Diabetes Mellitus with Alzheimer's Disease: Bioinformatics Analysis for the Potential Pathways and Characteristic Genes. | Biochem Genet | 2022 | https://conductscience.org/library/papers/34779951 | PubMed |
| 5 | 30104301 | The Legacy Effect in Type 2 Diabetes: Impact of Early Glycemic Control on Future Complications (The Diabetes & Aging Study). | Diabetes Care | 2019 | https://conductscience.org/library/papers/30104301 | PubMed |
| 6 | 33280500 | Autophagy alleviates hypoxia-induced blood-brain barrier injury via regulation of CLDN5 (claudin 5). | Autophagy | 2021 | https://conductscience.org/library/papers/33280500 | PubMed |
| 7 | 36596965 | Therapeutic Potentials of MicroRNA-126 in Cerebral Ischemia. | Mol Neurobiol | 2023 | https://conductscience.org/library/papers/36596965 | PubMed |
| 8 | 36179025 | Astrocytic NDRG2-PPM1A interaction exacerbates blood-brain barrier disruption after subarachnoid hemorrhage. | Sci Adv | 2022 | https://conductscience.org/library/papers/36179025 | PubMed |
| 9 | 37875994 | Methylglyoxal, a highly reactive dicarbonyl compound, as a threat for blood brain barrier integrity. | Fluids Barriers CNS | 2023 | https://conductscience.org/library/papers/37875994 | PubMed |
| 10 | 24309662 | Development, maintenance and disruption of the blood-brain barrier. | Nat Med | 2013 | https://conductscience.org/library/papers/24309662 | PubMed |
| 11 | 18539916 | Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. | N Engl J Med | 2008 | https://conductscience.org/library/papers/18539916 | PubMed |
| 12 | 28526762 | Exacerbation of Thromboinflammation by Hyperglycemia Precipitates Cerebral Infarct Growth and Hemorrhagic Transformation. | Stroke | 2017 | https://conductscience.org/library/papers/28526762 | PubMed |
| 13 | 25867911 | High glucose, glucose fluctuation and carbonyl stress enhance brain microvascular endothelial barrier dysfunction: Implications for diabetic cerebral microvasculature. | Redox Biol | 2015 | https://conductscience.org/library/papers/25867911 | PubMed |
| 14 | 31447320 | Extracellular miRNAs: From Biomarkers to Mediators of Physiology and Disease. | Cell Metab | 2019 | https://conductscience.org/library/papers/31447320 | PubMed |
| 15 | 35035668 | Methylglyoxal Scavengers Attenuate Angiogenesis Dysfunction Induced by Methylglyoxal and Oxygen-Glucose Deprivation. | Oxid Med Cell Longev | 2022 | https://conductscience.org/library/papers/35035668 | PubMed |
| 16 | 30400091 | Role of the Glyoxalase System in Alzheimer's Disease. | J Alzheimers Dis | 2018 | https://conductscience.org/library/papers/30400091 | PubMed |
| 17 | 33658432 | Blood-brain barrier dysfunction in ischemic stroke and diabetes: the underlying link, mechanisms and future possible therapeutic targets. | Anat Cell Biol | 2021 | https://conductscience.org/library/papers/33658432 | PubMed |
| 18 | 12162730 | Astrocyte-endothelial interactions and blood-brain barrier permeability. | J Anat | 2002 | https://conductscience.org/library/papers/12162730 | PubMed |
| 19 | 34763084 | Circular RNA circ-FoxO3 attenuates blood-brain barrier damage by inducing autophagy during ischemia/reperfusion. | Mol Ther | 2022 | https://conductscience.org/library/papers/34763084 | PubMed |
| 20 | 30228348 | Regulation of microRNA biogenesis and its crosstalk with other cellular pathways. | Nat Rev Mol Cell Biol | 2019 | https://conductscience.org/library/papers/30228348 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42533406 | Targeted Retention of Cationic Liposomes at the Inflamed Blood-Brain Barrier by Incorporating Mesenchymal Stem Cell Membrane. | Adv Healthc Mater | 2026 | https://conductscience.org/library/papers/42533406 | PubMed |
| 42237485 | Association Between the Cholesterol-HDL-Glucose (CHG) Index and 90-Day Functional Outcomes in Patients with Acute Ischemic Stroke. | Brain Behav | 2026 | https://conductscience.org/library/papers/42237485 | PubMed |
| 42189433 | PLAUR Exacerbates Neuroinflammation in Diabetic Ischemic Stroke by Driving Neutrophil-Mediated Blood-Brain Barrier Disruption and Reprogramming Microglial Metabolism. | Neuromolecular Med | 2026 | https://conductscience.org/library/papers/42189433 | PubMed |
| 41635599 | Admission NIHSS score and diabetes as independent predictors of in-hospital early neurological improvement following mechanical thrombectomy: a retrospective cohort study. | Front Neurol | 2025 | https://conductscience.org/library/papers/41635599 | PubMed |
| 41505036 | BMSC-Derived Exosomal miR-21a-5p Ameliorates Blood-Brain Barrier Injury and Hemorrhagic Transformation. | Mol Neurobiol | 2026 | https://conductscience.org/library/papers/41505036 | PubMed |
| 40855352 | Monocyte-to-albumin ratio outperforms triglyceride-glucose index in associating with stroke prevalence among diabetics: an NHANES cross-sectional study. | Eur J Med Res | 2025 | https://conductscience.org/library/papers/40855352 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39593147
GET https://conductscience.org/api/papers/v1/39593147/references?page=2